HLS Therapeutics Inc (FRA:74D)
€ 2.42 -0.10 (-3.97%) Market Cap: 81.25 Mil Enterprise Value: 109.00 Mil PE Ratio: 0 PB Ratio: 1.63 GF Score: 63/100

HLS Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 26, 2026 / 02:00PM GMT
Release Date Price: €2.44 (-1.61%)
Operator;Ryan Lennox
HLS Therapeutics Inc - Senior Vice President -

Hello, and welcome to the Annual Meeting of Shareholders of HLS Therapeutics, Inc. Please note that today's meeting is being recorded. If you participate in today's meeting and disclose personal information, you'll be deemed to the consent to the recording, transfer, and use the same. If you disclose personal information of another person in today's meeting, you'll be deemed to represent and warrant to ComputerShare and the corporation that you first obtained all required consents for the disclosure, recording, transfer, and use of such personal information from all appropriate persons before your disclosure.

During the meeting, registered shareholders and duly appointed proxy holders who have signed into the meeting using their control number or invitation code may submit questions or comments at any time by clicking the Q&A tab.

It is now my pleasure to turn today's meeting over to Ryan Lennox, Senior Vice President, Legal, HR, and Compliance of HLS Therapeutics, Inc. The floor is yours.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot